𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High resolution breakpoints of the Philadelphia translocation in patients with chronic myelogenous leukemia

✍ Scribed by Shinichi Misawa; Shoichiro Tsuda; Masafumi Taniwaki; Tatsuro Takino; Tatsuo Abe


Publisher
Nature Publishing Group
Year
1987
Tongue
English
Weight
595 KB
Volume
32
Category
Article
ISSN
1435-232X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Philadelphia-positive chronic myelogenou
✍ Bartram, Claus R. ;Bross-Bach, Ulrike ;Schmidt, Helmuth ;Waller, Hans D. πŸ“‚ Article πŸ“… 1987 πŸ› Springer-Verlag βš– 545 KB

We report on the first Philadelphia chromosome (Ph) positive chronic myelogenous leukemia (CML) characterized by a rearrangement within the 5' part of the bcr gene on chromosome 22, but outside the restricted breakpoint cluster region. In situ hybridization studies revealed a translocation of the c-

Thiotepa for the treatment of thrombocyt
✍ Edgardo J. Rodriguez-Monge; Jorge E. Cortes; Susan O'Brien; Moshe Talpaz; Hagop πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 102 KB πŸ‘ 3 views

## Background: Patients with chronic myelogenous leukemia (cml) occasionally experience persistent thrombocythemia despite having adequate white blood cell (wbc) counts. trimethylenethiophosphoramide (thiotepa) is an alkylating agent that significantly inhibits platelet production. ## Methods: Th

Philadelphia chromosome-negative chronic
✍ Jorge E. Cortes; Moshe Talpaz; Miloslav Beran; Susan M. O'Brien; Mary B. Rios; S πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 594 KB

Background. Five to 10% of patients with chronic myelogenous leukemia (CML) do not have the Philadelphia chromosome (Ph), but one-third of them have rearrangements of the breakpoint cluster region (BCR-positive). Methods. The authors analyzed the characteristics, treatment response, and prognosis o